Aging Overview

Aging gene

Gene name: HMGA2
Aging type: Accelerate
Aging characteristic:
Tissue type: --
Cell name: WI-38
Gene ID: 8091
Category: protein coding
Phenotype: Retinoblastoma
Experimental category: L
PMID: 23969248
Experiment: SA-β-gal activity assay//qPCR//Western blot
Description: We found that the ectopic overexpression of HMGA2 led to elevated SA-β-galactosidase staining and acquisition of the SAHF-like chromatin foci in the nuclei. Meanwhile, the expression levels of the senescence-related proteins, such as p16, p21, p53 and phosphorylated p53, were prominently increased. The transcription level of HDM2 that reduces the stability of p53 protein was decreased together with a slightly up-regulated p14ARF, an inhibitor of HDM2, in WI38 cells expressing HMGA2 . Apparently, these results indicate that HMGA2 can induce the senescence phenotypes in WI38 cells.


Regulatory relationship

Target gene: E2F
Official symbol(s): E2F1
R-AG-Target gene: Downregulation
Subcategory: Unclear
Target gene experiment: Western blot
Target gene description: Surprisingly, both HMGA2 and Rb were detected in the same protein complex in our model (data not shown), together with the down-regulation of E2F target genes in WI38 cells in response to HMGA2 overexpression.

Regulatory pathway: RB
R-AG-Pathway: --
Official symbol(s): retinoblastoma
Pathway experiment: Western blot//qPCR//RT-PCR//Immunofluorescence
Pathway description: To further test whether Rb is a crucial factor in SAHF formation induced by HMGA2, E7 protein was used as the specific inhibitor of Rb , and the effect of E7 protein on the degradation of Rb was confirmed by Western blotting . Interestingly, we found that E7 protein was able to partly abolish the SAHF formation induced by HMGA2, as revealed by cellular immunofluorescence and decreased percentage of cells with SAHF .Furthermore, as another inhibitor targeted to Rb, SV40 had a similar effect to decrease the HMGA2-induced SAHF formation .


Aging network

Annotation:

The green line represents Upregulation.

The purple line represents Downregulation.

The orange line represents Activation.

The yellow line represents Inhibition.

The gray line represents Unclear.



Pathway view

About risk SNP and eQTL

Loading,please wait...